NCT04113044

Brief Summary

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Trial Health

82
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
6 countries

15 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Feb 2021Dec 2026

First Submitted

Initial submission to the registry

September 20, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 2, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

5.9 years

First QC Date

September 20, 2019

Last Update Submit

March 5, 2026

Conditions

Keywords

PROHOOSKOOSFAAMPROMISQuickDASHPSEQPAM

Outcome Measures

Primary Outcomes (2)

  • Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis

    * Radiographic measurements o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\]) * Patient related outcomes * Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference * Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms) * Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms) * Loading/Activity pattern analysis: * Number of steps with weight-bearing \>80% body-weight (weight in kg) * pressure distribution \[N/cm2\] * center of pressure \[mm\] * ground reaction forces \[N\] * temporal and spatial parameters (time spent during gait \[min\], stance time \[s\], swing time \[s\], double support time \[s\], cadence \[r/min\], cycle time \[s\])

    from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM

    PROs that measure physical limitations: * PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities) * PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function) * Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability) * HOOS-12 * KOOS-12 * Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale) * PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)

    from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)

Secondary Outcomes (11)

  • PROMIS Pain Interference

    from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • PROMIS Depression

    from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • PROMIS Anxiety

    from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • PROMIS Ability to Participate in Social Roles and Activities

    from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • Pain Self-Efficacy Questionnaire (PSEQ)-2

    from the treatment assessment until 12 months after the treatment (surgical or not-surgical)

  • +6 more secondary outcomes

Interventions

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

Also known as: Patient Reported Outcomes

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients over 18 who have have suffered an isolated fracture of one of the following five bones: 1. proximal femur (hip); 2. tibial shaft (shin bone); 3. ankle; 4. proximal humerus (shoulder); and 5: distal radius ( wrist)

You may qualify if:

  • Age 18 years and older
  • Diagnosis of one of, isolated injury
  • Hip fracture
  • Tibial shaft fracture (with and without associated fibular fracture)
  • Ankle/pilon fracture
  • Proximal humerus fracture
  • Distal radius fracture
  • English, German, or Spanish speaking
  • Informed consent obtained, i.e.:
  • Ability to understand the content of the patient information/ICF
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated EC/IRB approved written informed consent

You may not qualify if:

  • More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
  • Patients with multiple fractures
  • Pathological fractures due to cancer
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the study period
  • Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
  • Prisoners
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  • Patients unable to likely achieve anticipated Follow-up (FU)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Cedars-Sinai Department of Orthopaedics

Los Angeles, California, 90048, United States

Location

University of Miami, Jackson Memorial Hospital Ryder Trauma Center

Miami, Florida, 33136, United States

Location

Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative

Boston, Massachusetts, 02114, United States

Location

The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin

Austin, Texas, 78712, United States

Location

Univ.-Klinik für Orthopädie und Traumatologie

Innsbruck, 6020, Austria

Location

Fundación Santa Fe de Bogotá

Bogotá, 110121, Colombia

Location

Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin

Berlin, 13353, Germany

Location

University Hospital Freiburg

Freiburg im Breisgau, 79106, Germany

Location

Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery

Homburg, 66421, Germany

Location

Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau

Murnau am Staffelsee, 82418, Germany

Location

Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen

Tübingen, 72076, Germany

Location

University Medical Center Groningen

Groningen, 9700, Netherlands

Location

Isala Clinics

Zwolle, 8000, Netherlands

Location

Barts Health NHS Trust

London, E14DG, United Kingdom

Location

Oxford University Hospitals NHS Foundation Trust

Oxford, OX39DU, United Kingdom

Location

MeSH Terms

Conditions

Hip FracturesTibial FracturesAnkle FracturesShoulder FracturesWrist Fractures

Interventions

Patient Reported Outcome Measures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesAnkle InjuriesShoulder InjuriesWrist InjuriesArm Injuries

Intervention Hierarchy (Ancestors)

Health Care SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Services ResearchHealth PlanningHealth Care Economics and OrganizationsPatient Outcome AssessmentOutcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationHealth Care Evaluation MechanismsPublic HealthEnvironment and Public Health

Study Officials

  • Marilyn Heng

    Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative

    PRINCIPAL INVESTIGATOR
  • Prakash Jayakumar

    Dell Medical School, University of Texas at Austin

    PRINCIPAL INVESTIGATOR
  • Tim Pohlemann

    Saarland University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2019

First Posted

October 2, 2019

Study Start

February 1, 2021

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations